Abstract

Background: Transcatheter aortic valve implantation (TAVI) is a new method for patients with severe aortic stenosis at high surgical risk, such as previous cardiac surgery. The presence of mechanical mitral prosthesis might complicate TAVI because of possible interference between both prostheses. Some reports have already demonstrated the feasibility of TAVI in such patients. Case Reports: We report 2 patients with severe symptomatic aortic stenosis who had prior mitral valve replacement that successfully underwent TAVI with Edwards Sapien and CoreValve aortic prosthesis, re- spectively. Computed tomographic angiography (CTA) was useful for the assessment of the distance between both aor- tic and mitral prosthesis annuli. Transesophageal echocardiography was crucial for precise positioning of TAV. There were no special technical tips besides precise positioning of the valve prosthesis. In case of Core Valve the goal was the positioning at “zero point” and in case of Edwards Sapien valve a “half-on-half” position according to natural aortic valve. We observed no deformation or dysfunction of aortic and mitral prosthesis in any of the patients. Balloon valvu- loplasty prior to implantation helps to observe the mutual effect of the new aortic valve and pre-existent mitral prosthe- sis. Conclusions: We conclude that TAVI can be safely and successfully performed in patients with mechanical mitral prosthesis carefully considering the altered anatomical conditions. Skillfulness and TAVI experience of the operators should not be neglected.

Highlights

  • Transcatheter aortic valve implantation (TAVI) is a new method for patients with severe aortic stenosis at high surgical risk, such as previous cardiac surgery

  • Case Reports: We report 2 patients with severe symptomatic aortic stenosis who had prior mitral valve replacement that successfully underwent TAVI with Edwards Sapien and CoreValve aortic prosthesis, respectively

  • In this paper we demonstrate our experience with TAVI in 2 patients after previous mitral valve replacement

Read more

Summary

Background

Transcatheter aortic valve implantation (TAVI) is a relatively new option for the treatment of severe symptomatic aortic stenosis in high-risk patients not being considered for surgery because of significant comorbidities [1]. TAVI can be complicated in patients with previous mitral valve replacement due to possible interference between the mechanical mitral and percutaneous aortic valve prosthesis. Emerged in the last years showing the feasibility of TAVI via transfemoral as well as transapical approach with both available percutaneous aortic prostheses (Edwards Sapien, Edwards Lifesciences, Inc., Irvine, California and CorveValve, Inc., Irvine, California) in patients with artificial mitral valve [3,4,5,6,7,8]. The TAVR program was approved by Slovenian Ethic Committee, Scientific Board of University Medical Center of Ljubljana and Ministry of Health of Slovenia

Patient 1
Patient 2
Findings
Discussion and Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call